MRC1 and colorectal carcinoma: These include sex‐ and MMR gene‐specific cumulative CRC risk without colonoscopic surveillance, HR associated with colonoscopic surveillance by time since last colonoscopy and the recommended surveillance interval, and the effect of colonoscopy on CRC incidence by MMR gene (i.e., whether CRC risk reduction from colonoscopy differs by MMR gene).